Evidence from gene knockout studies implicates Asc‐1 as the primary transporter mediating d‐serine reuptake in the mouse CNS
- 1 March 2007
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 25 (6) , 1757-1766
Abstract
In the mammalian central nervous system, transporter‐mediated reuptake may be critical for terminating the neurotransmitter action of d‐serine at the strychnine insensitive glycine site of the NMDA receptor. The Na+ independent amino acid transporter alanine–serine–cysteine transporter 1 (Asc‐1) has been proposed to account for synaptosomal d‐serine uptake by virtue of its high affinity for d‐serine and widespread neuronal expression throughout the brain. Here, we sought to validate the contribution of Asc‐1 to d‐serine uptake in mouse brain synaptosomes using Asc‐1 gene knockout (KO) mice. Total [3H]d‐serine uptake in forebrain and cerebellar synaptosomes from Asc‐1 knockout mice was reduced to 34 ± 5% and 22 ± 3% of that observed in wildtype (WT) mice, respectively. When the Na+ dependent transport components were removed by omission of Na+ ions in the assay buffer, d‐serine uptake in knockout mice was reduced to 8 ± 1% and 3 ± 1% of that measured in wildtype mice in forebrain and cerebellum, respectively, suggesting Asc‐1 plays a major role in the Na+ independent transport of d‐serine. Potency determination of d‐serine uptake showed that Asc‐1 mediated rapid high affinity Na+ independent uptake with an IC50 of 19 ± 1 µm. The remaining uptake was mediated predominantly via a low affinity Na+ dependent transporter with an IC50 of 670 ± 300 µm that we propose is the glial alanine–serine–cysteine transporter 2 (ASCT2) transporter. The results presented reveal that Asc‐1 is the only high affinity d‐serine transporter in the mouse CNS and is the predominant mechanism for d‐serine reuptake.Keywords
This publication has 39 references indexed in Scilit:
- d-Amino acids in the central nervous system in health and diseaseMolecular Genetics and Metabolism, 2005
- d-Serine enhances impaired long-term potentiation in CA1 subfield of hippocampal slices from aged senescence-accelerated mouse prone/8Neuroscience Letters, 2005
- D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophreniaBiological Psychiatry, 2005
- Serine Racemase Modulates Intracellular D-Serine Levels through an α,β-Elimination ActivityJournal of Biological Chemistry, 2005
- Glutamate as a therapeutic target in psychiatric disordersMolecular Psychiatry, 2004
- Spatial Memory Deficits Induced by Perinatal Treatment of Rats with PCP and Reversal Effect of D-SerineNeuropsychopharmacology, 2004
- D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneuronsThe Journal of Physiology, 2003
- Uptake of D‐serine by synaptosomal P2 fraction isolated from rat brainSynapse, 2001
- Identification and Characterization of a Na+-independent Neutral Amino Acid Transporter That Associates with the 4F2 Heavy Chain and Exhibits Substrate Selectivity for Small Neutral d- and l-Amino AcidsJournal of Biological Chemistry, 2000
- Cloning and Functional Characterization of a System ASC-like Na+-dependent Neutral Amino Acid TransporterJournal of Biological Chemistry, 1996